Close filters
 
  •  
 
1 From 2
No results were found for the filter!
Acquired Cold Urticaria Severity Index (ACUSI) - non-commercial use Acquired Cold Urticaria Severity Index (ACUSI) - non-commercial use
The ACUSI is a short questionnaire to assess the severity of disease in patients with acquired cold urticaria. The ACUSI is easy to use and evaluate, meaningful and suitable for all patients with acquired cold urticaria, regardless of the underlying causes. The ACUSI is used in the routine care of patients with cold urticaria, in research projects and in clinical studies....
0.00€ *
Angioedema Activity Score (AAS) - non-commercial use Angioedema Activity Score (AAS) - non-commercial use
The Angioedema Activitiy Score (AAS) is a validated, easy to use tool to determine disease activity in patients with recurrent angioedema, independent of its underlying causes. The AAS is designed to be used by patients for their daily documentation of swelling episodes including their duration, severity and impact on daily functioning and appearance. The AAS was developed...
0.00€ *
Angioedema Control Test (AECT) - non-commercial use Angioedema Control Test (AECT) - non-commercial use
The Angioedema Control Test (AECT) is a validated, user-friendly instrument (Patient Reported Outcome Measure) to assess disease control in patients with recurrent angioedema. The AECT can be used in patients with histamine-mediated, bradykinin-mediated and idiopathic recurrent angioedema. The AECT is a retrospective instrument and can be evaluated directly, quickly and...
0.00€ *
Angioedema Quality of Life Questionnaire (AE-QoL) - non-commercial use Angioedema Quality of Life Questionnaire (AE-QoL) - non-commercial use
The Angioedema Quality of Life Questionnaire (AE-QoL) is the first and only angioedema-specific quality of life (QoL) questionnaire. It is a short, valid and reliable instrument to determine QoL impairment in all patients with recurrent angioedema, independent of its underlying causes. AE-QoL was developed by a Charité team of scientists led by Dr. Karsten Weller and Dr....
0.00€ *
Cholinergic Urticaria Activity Score (CholUAS) - non-commercial use Cholinergic Urticaria Activity Score (CholUAS) - non-commercial use
The CholUAS is a disease-specific questionnaire to assess the disease activity in patients with cholinergic urticaria. It consists of a daily three-item questionnaire and is quick and easy to use for patients. The CholUAS was developed at the Charité by a team headed by Sabine Altrichter, Karsten Weller and Marcus Maurer. The questions included in the CholUAS were created...
0.00€ *
Cholinergic Urticaria Quality of Life Questionnaire (CholU-QoL) - non-commercial use Cholinergic Urticaria Quality of Life Questionnaire (CholU-QoL) - non-commercial use
The Quality of Life Questionnaire for Patients with Cholinergic Urticaria (CholU-QoL) is the first and only available quality of life questionnaire specifically designed for patients with cholinergic urticaria. CholU-QoL is easy to use and has been validated specifically for patients with cholinergic urticaria. The CholU-QoL was developed at the Charité by a team headed by...
0.00€ *
Cold Urticaria Activity Score (ColdUAS) - non-commercial use Cold Urticaria Activity Score (ColdUAS) - non-commercial use
The Cold Urticaria Activity Score (ColdUAS) is the first instrument for assessing disease activity in patients with cold urticaria (ColdU). The questionnaire is simple and user-friendly, designed for adults and adolescents 12 years and older. The ColdUAS was developed by a team of urticaria experts at Charité University, led by PD Dr. Dorothea Terhorst-Molawi, PD Dr. Karsten...
0.00€ *
Mastocytosis Quality of Life Questionnaire (MC-QoL) - non-commercial use Mastocytosis Quality of Life Questionnaire (MC-QoL) - non-commercial use
The Mastocytosis Quality of Life Questionnaire (MC-QoL) is the first and only mastocytosis-specific quality of life (QoL) questionnaire available so far. It is a short, valid and reliable instrument to determine QoL impairment in patients with cutaneous and indolent systemic mastocytosis. MC-QoL was developed by a Charité team of scientists led by PD Dr. Frank Siebenhaar, PD...
0.00€ *
NEW
Mastozytose Control Test (MCT) - non-commercial use Mastozytose Control Test (MCT) - non-commercial use
The Mastocytosis Control Test (MCT) is an easy-to-use disease-specific tool to assess disease control in patients with cutaneous or indolent systemic mastocytosis. The MCT is a retrospective tool and can be used directly, quickly, and easily during patient presentation. A cut off value helps distinguish patients with poorly controlled disease from patients with...
0.00€ *
Mastozytose-Aktivitäts-Score (MAS) - non-commercial use Mastozytose-Aktivitäts-Score (MAS) - non-commercial use
This questionnaire for assessing disease activity in patients with cutaneous and indolent systemic mastocytosis is a symptom questionnaire that was specially developed for patients with mastocytosis. The Mastocytosis Activity Score (MAS) is easy to use and has been validated for patients with cutaneous and indolent systemic mastocytosis. The MAS was developed at Charité by a...
0.00€ *
Prurigo Control Test (PCT) - non-commercial use Prurigo Control Test (PCT) - non-commercial use
The Prurigo Control Test (PCT) is a validated, user-friendly instrument (Patient Reported Outcome Measure) to assess disease control in patients with chronic prurigo. The PCT is a retrospective instrument and can be evaluated directly, quickly and easily. Its cut-off value of 10 points helps to distinguish patients with poorly controlled chronic prurigo from patients with...
0.00€ *
Severity Index Cold Urticaria (SICU) - non-commercial use Severity Index Cold Urticaria (SICU) - non-commercial use
The SICU is the first and so far the only validated questionnaire to assess the severity of disease in patients with cold urticaria. The SICU is easy to use and evaluate, meaningful and suitable for all patients with cold urticaria, regardless of the underlying causes. The SICU will be used in the routine care of patients with cold urticaria to improve and provide the best...
0.00€ *
1 From 2
Viewed